You're reading the free version. Trader adds the live tape and alerts.
Start tracking
OTLK Buy Disclosure
Kenyon Lawrence A · SEC Form 4 · Filed Aug 14, 2026
Buy
Reported value range
Not reported
Kenyon Lawrence A Chief Financial Officer
OTLK
Outlook Therapeutics
OTLK
Transaction date
Aug 14, 2026
Public filing date
Aug 14, 2026
Filing lag
Filed same day
OTLK daily price context
Close on/before transaction
$0.76
Aug 14, 2026
First close after public filing
$0.67
Aug 17, 2026
30-day return after filing
-5.1%
Through Sep 14, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 101,010 shares
- SEC ownership
- Direct
- Transaction code
- P
- Form
- 4
- Filing identifier
- 0001649989-26-000009
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
Not reported
Buys / sales
2 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Outlook Therapeutics, Inc. OTLK | Buy | Aug 14, 2026 | Not reported |
| Outlook Therapeutics, Inc. OTLK Current | Buy | Aug 14, 2026 | Not reported |